TOPIC

HKEX and the future of biotech

Paid Post:HKEX
HKEX and the future of biotech
At the heart of Asia’s largest biotech fundraising hub, HKEX fuels the global post-pandemic recovery story as an international capital market for biotech companies, connecting innovation, ideas and opportunities.

Hong Kong’s biotech investment ecosystem is booming after listing reforms

HKEX’s listing reforms launched in 2018 opened a new pathway for pre-revenue biotech companies to raise capital, fuelling an era of growth that has made Hong Kong the world’s second-largest fundraising biotech hub for the sector

Paid Post:
HKEX
Advertisement
Advertisement
Advertisement